United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

1
Player Avatar Turtlebale (55.12) Submitted: 6/6/2011 11:57:47 AM : Outperform Start Price: $58.86 UTHR Score: -24.94

negative response to clinical data is an overreaction

Featured Broker Partners


Advertisement